Black Diamond Therapeutics Cash Flow Statement (2018-2026) | BDTX

Cash Flow Statement Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-51.68M-43.00M-26.10M-25.98M-30.05M-57.27M-22.23M-21.99M-30.81M-55.06M-21.61M-20.69M-49.91M-24.98M-18.82M54.02M-12.89M-15.32M-17.57M-11.38M
Depreciation and Depletion (Quarter)
0.02M0.04M0.12M0.12M0.13M0.13M0.13M0.12M0.11M0.12M0.09M0.09M0.09M0.09M0.09M0.09M0.09M0.09M0.07M0.03M
Share-based Compensation (Quarter)
4.56M3.01M3.38M3.38M3.25M2.66M2.91M2.67M2.65M2.75M1.54M1.71M5.29M1.99M1.64M1.70M1.78M1.74M1.41M1.45M
Cash from Operations (Quarter)
-25.16M-26.48M-24.05M-28.60M-18.07M-16.48M-21.94M-20.03M-14.37M-18.36M-13.96M-21.20M-14.73M-11.32M-15.05M53.41M-9.16M-7.85M-6.79M-10.23M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
Depreciation & Amortization (CF) (Quarter)
0.02M0.04M0.12M0.12M0.13M0.13M0.13M0.12M0.11M0.12M0.09M0.09M0.09M0.09M0.09M0.09M0.09M0.09M0.07M0.03M
Change in Working Capital
Change in Account Payables (Quarter)
-0.36M0.63M-0.69M-2.22M0.34M3.54M-3.88M1.17M-0.34M-1.86M1.63M-1.13M-0.43M1.21M2.04M-1.38M-1.86M0.20M-0.40M2.39M
Change in Accured Expenses (Quarter)
4.52M3.34M-1.98M-1.96M0.12M-2.09M-1.94M-3.58M1.36M3.21M2.95M-1.64M2.00M1.15M-2.26M-2.35M1.81M-1.46M0.58M-3.59M
Other Working Capital Changes (Quarter)
-0.43M2.92M-3.89M-0.69M-0.70M-0.71M-0.74M-0.75M-0.68M-0.87M0.04M-0.82M-0.83M1.88M-0.26M-0.90M-0.91M-0.93M-0.97M0.92M
Investing Activities
Capital Expenditures (Quarter)
0.89M-0.90M-0.08M-0.01M0.01M0.19M0.03M0.34M-0.04M-0.04M-0.04M-0.04M-0.04M-0.04M-0.04M
Sales of Property, Plant and Equipment (Quarter)
0.01M0.04M0.05M0.01M0.01M0.01M0.00M0.00M
Change in Acquisitions & Divestments (Quarter)
50.10M39.19M48.50M37.24M20.00M30.45M26.00M24.81M17.08M8.25M28.04M38.50M40.50M30.00M30.75M32.00M30.58M23.50M33.01M19.50M
Cash from Investing Activities (Quarter)
48.20M35.70M43.24M16.73M19.81M14.51M2.32M24.81M17.18M-37.88M12.25M-13.73M0.74M2.19M27.77M8.55M-59.15M8.59M-2.89M19.50M
Financing Activities
Other financing activities (Quarter)
0.18M0.06M0.15M0.05M-0.03M0.05M0.08M-0.05M0.15M0.36M0.25M0.29M0.03M
Cash from Financing Activities (Quarter)
0.18M0.06M0.15M0.05M-0.03M0.05M71.93M-0.05M4.13M21.38M-0.25M0.29M0.03M-0.12M0.13M-0.20M-0.18M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
71.85M3.98M21.01M-0.50M
Additional items
Change in Cash (Quarter)
23.22M9.28M19.20M-11.72M1.74M-1.92M-19.64M4.83M2.81M15.68M-1.75M-30.80M7.39M-9.38M13.01M61.99M-68.43M0.87M-9.87M9.08M
Free Cash Flow (Quarter)
-26.06M-25.59M-23.96M-28.59M-18.07M-16.67M-21.94M-20.03M-14.37M-18.36M-13.99M-21.20M-15.06M-11.28M-15.01M53.45M-9.12M-7.81M-6.74M-10.19M
Net Cash Flow (Quarter)
23.22M9.28M19.20M-11.72M1.74M-1.92M-19.64M4.83M2.81M15.68M-1.75M-30.80M7.39M-9.38M13.01M61.99M-68.43M0.87M-9.87M9.08M